首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula Qing-Luo-Yin
【2h】

An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula Qing-Luo-Yin

机译:中医网络药理综合平台及其在中药清罗阴中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The scientific understanding of traditional Chinese medicine (TCM) has been hindered by the lack of methods that can explore the complex nature and combinatorial rules of herbal formulae. On the assumption that herbal ingredients mainly target a molecular network to adjust the imbalance of human body, here we present a-self-developed TCM network pharmacology platform for discovering herbal formulae in a systematic manner. This platform integrates a set of network-based methods that we established previously to catch the network regulation mechanism and to identify active ingredients as well as synergistic combinations for a given herbal formula. We then provided a case study on an antirheumatoid arthritis (RA) formula, Qing-Luo-Yin (QLY), to demonstrate the usability of the platform. We revealed the target network of QLY against RA-related key processes including angiogenesis, inflammatory response, and immune response, based on which we not only predicted active and synergistic ingredients from QLY but also interpreted the combinatorial rule of this formula. These findings are either verified by the literature evidence or have the potential to guide further experiments. Therefore, such a network pharmacology strategy and platform is expected to make the systematical study of herbal formulae achievable and to make the TCM drug discovery predictable.
机译:缺乏能够探索草药配方的复杂性质和组合规则的方法,阻碍了对中药(TCM)的科学理解。在假设草药成分主要针对分子网络以调节人体失衡的假设下,我们在此提出了一个自行开发的TCM网络药理平台,用于系统地发现草药配方。该平台集成了我们先前建立的一组基于网络的方法,以捕获网络调节机制并识别给定草药配方的活性成分以及协同组合。然后,我们提供了一个抗风湿性关节炎(RA)配方“青罗阴”(QLY)的案例研究,以证明该平台的可用性。我们揭示了QLY针对RA相关关键过程(包括血管生成,炎症反应和免疫反应)的目标网络,在此基础上,我们不仅预测了QLY的活性成分和协同成分,而且还解释了该配方的组合规则。这些发现要么得到文献证据的证实,要么具有指导进一步实验的潜力。因此,期望这种网络药理学策略和平台能够使草药配方的系统研究成为可能,并使中药发现成为可预测的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号